NLS Pharma Shares Fall After Mazindol ER Interim Data Shows 39% Improvement On Sleepiness Scale
NLS Pharmaceutics Ltd (NASDAQ:NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol…
NLS Pharmaceutics Announces Interim Top-Line Data For Quilience In Patients With Narcolepsy; Co. Reports ‘Clinically meaningful results with Mazindol ER exhibiting a 39% reduction in ESS from baseline’
Clinically meaningful results with Mazindol ER exhibiting a 39% reduction in ESS from baseline (-4.3 points placebo-adjusted); confirms statistical powering of the ongoing Phase 2a trial
Safety and
25 Stocks Moving in Monday’s Pre-Market Session
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
47 Biggest Movers From Yesterday
Gainers
Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share.
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
NLS Pharmaceutics Ltd (NASDAQ: NLSP) shares are trading higher after the Company announced to present interim topline data from its Phase 2a trial evaluating its lead product candidate, Quilience (Mazindol ER), for narcolepsy at World Sleep Congress 2022.
58 Biggest Movers From Yesterday
Gainers
Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs
after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
45 Biggest Movers From Yesterday
Gainers
ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55.
23 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a Q3 net loss of $3.9 million.